The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Steve Christo-Corbis/Getty Images Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a new clinical trial. MASH is an advanced stage of metabolic dysfunction ...

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

FOX 5 Atlanta Wegovy may treat liver disease Posted: May 13, 2025 | Last updated: May 13, 2025 The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients ...

Wegovy, a highly effective medication used to treat obesity, shows promise in treating a serious form of liver disease in a new clinical trial. The medication resolved liver inflammation in nearly ...